The University of Chicago Header Logo

Connection

Richard A. Larson to Receptors, Immunologic

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Receptors, Immunologic.
Richard A. Larson
Connection Strength
0.013
Receptors, Immunologic
  1. Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420. Clin Cancer Res. 2002 Sep; 8(9):2812-9.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.